Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.425 USD | +1.06% | +2.90% | +5.97% |
04-24 | Precigen, Inc. to Present Late-Breaking Abstract for Pivotal Phase 2 Study Data for PRGN- 2012 AdenoVerse Immunotherapy | CI |
03-25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.97% | 351M | |
+26.06% | 661B | |
+26.74% | 566B | |
-6.76% | 352B | |
+19.50% | 332B | |
+3.46% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.32% | 145B |
- Stock Market
- Equities
- PGEN Stock
- News Precigen, Inc.
- Precigen : Appoints CFO